Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03523377 · ClinicalTrials.gov registry record · NA

Overnight Fasting After Completion of Therapy: The OnFACT Study

A NA study of Childhood Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT03523377 is a NA study of Childhood Cancer Survivors that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 28 participants, below the 991-participant average among 6 other Childhood Cancer Survivors trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03523377, a NA study of Childhood Cancer Survivors, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test whether regularly not eating for at least 14 hours overnight ("intermittent fasting") is feasible and can improve blood sugar.

Conditions Studied

Interventions

  • OTHER prolonged overnight fasting
  • OTHER usual care

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2018-04-27
Est. Completion 2026-04
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03523377

The ClinicalTrials.gov registry entry for NCT03523377 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 991-participant average among 6 other Childhood Cancer Survivors trials with a reported enrollment target (97% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Childhood Cancer Survivors appearing as the primary indexed condition, and to 2 interventions - of which prolonged overnight fasting is the first listed.

NCT03523377 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03523377 about?

NCT03523377 is a clinical study titled "Overnight Fasting After Completion of Therapy: The OnFACT Study". The purpose of this study is to test whether regularly not eating for at least 14 hours overnight ("intermittent fasting") is feasible and can improve blood sugar.

What is the current status of trial NCT03523377?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2018-04-27. Estimated completion is 2026-04.

What conditions does trial NCT03523377 study?

This clinical trial studies the following conditions: Childhood Cancer Survivors.

What interventions are being tested in trial NCT03523377?

The interventions under investigation include: prolonged overnight fasting (OTHER), usual care (OTHER).

Who is sponsoring clinical trial NCT03523377?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03523377 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Cancer Survivors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.